Pear Therapeutics Inc 's

Name: Pear Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PEAR Sales vs. its Competitors Q4 2022

Comparing the current results to its competitors, Pear Therapeutics Inc reported Revenue decrease in the 4 quarter 2022 year on year by -39.04 %, faster than the overall decrease of Pear Therapeutics Inc 's competitors by -33.32 %, recorded in the same quarter.

• List of PEAR Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Pear Therapeutics Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< PEAR Stock Performance Comparisons

<< See the full list of PEAR competitors

Overall company Market Share Q4 2022

Overall company, revenue fell by -39.04 % company lost market share within this segment. << More on PEAR Market Share.

*Market share is calculated based on total revenue.

PEAR's Stock Performance relative to its Competitors

Publicly Traded Peers of Pear Therapeutics Inc

Akili Inc
Share Performance

+2.88%

30 Days

Akili Inc

Profile

Akili Inc is a technology-based healthcare company that develops digital therapeutics to treat cognitive disorders. Their business model revolves around creating and commercializing clinically validated video games and mobile apps, which serve as non-pharmacological treatments for conditions like ADHD and autism.

More about Akili Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 33.924 mill.	$ 1.948 mill.	$ -48.545 mill.

Sources: Pear Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, August 29, 2026 5:44 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Pear Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.